Taken together with our previous findings in APP- and tau-Tg mice, the present results suggest that nasal rifampicin could be a promising remedy for the prevention of neurodegenerative dementia including Alzheimer’s disease, frontotemporal dementia, and DLB. Here, MAPT is linked to frontotemporal dementia.